Property News · January 21, 2026

CE-Ventures invests in $55mn Series A to advance Noonan syndrome therapies

Funding will accelerate development of first-in-class small-molecule drugs for a condition with no approved targeted treatments
The post CE-Ventures invests in $55mn Series A to advance Noonan syndrome therapies appeared first on Arabian Business: Latest News on the Middle East, Real Estate, Finance, and More.

Source : arabianbusiness.com
Read more…CE-Ventures invests in mn Series A to advance Noonan syndrome therapies